Literature DB >> 1621414

Immunization of pigs against Actinobacillus pleuropneumoniae with two recombinant protein preparations.

A Rossi-Campos1, C Anderson, G F Gerlach, S Klashinsky, A A Potter, P J Willson.   

Abstract

Two Actinobacillus pleuropneumoniae serotype 7 antigens were expressed in Escherichia coli and tested for their protective efficacy in an experimental pig model. The antigens used were a fusion protein containing the carboxy-terminal 70% of the +/- 103 kDa cytolysin and a full length 60 kDa protein which has been shown previously to bind transferrin. Pigs were immunized twice with 25 micrograms of either or both preparations. All pigs developed a strong humoral immune response comparable to that induced by infection. Upon challenge with an A. pleuropneumoniae serotype 7 strain, all immunized groups were less affected by the disease and showed significantly lower mortality than the controls (p less than 0.1). Pigs receiving both antigens had a tendency to recover faster than the controls or animals which were vaccinated with only one antigen. Protection was serotype-specific since no cross-protection was detected following challenge with an A. pleuropneumoniae serotype 1 strain. A dose-response experiment using the single antigens at 200, 50 or 12.5 micrograms per dose showed no difference in protection among the groups.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1621414     DOI: 10.1016/0264-410x(92)90349-o

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  43 in total

1.  Characterization of a multigene family undergoing high-frequency DNA rearrangements and coding for abundant variable surface proteins in Mycoplasma agalactiae.

Authors:  M D Glew; L Papazisi; F Poumarat; D Bergonier; R Rosengarten; C Citti
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

2.  Development and characterization of protective Haemophilus parasuis subunit vaccines based on native proteins with affinity to porcine transferrin and comparison with other subunit and commercial vaccines.

Authors:  Rafael Frandoloso; Sonia Martínez; Elías F Rodríguez-Ferri; María José García-Iglesias; Claudia Pérez-Martínez; Beatriz Martínez-Fernández; César B Gutiérrez-Martín
Journal:  Clin Vaccine Immunol       Date:  2010-10-06

3.  Immunization with recombinant transferrin binding protein B enhances clearance of nontypeable Haemophilus influenzae from the rat lung.

Authors:  D C Webb; A W Cripps
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

4.  Cloning and characterization of tbpA gene encoding transferrin-binding protein (TbpA) from Pasteurella multocida serogroup B:2 (strain P52).

Authors:  S B Shivachandra; A A Kumar; J Amaranath; S Joseph; S K Srivastava; P Chaudhuri
Journal:  Vet Res Commun       Date:  2005-08       Impact factor: 2.459

5.  Endobronchial inoculation with Apx toxins of Actinobacillus pleuropneumoniae leads to pleuropneumonia in pigs.

Authors:  E M Kamp; N Stockhofe-Zurwieden; L A van Leengoed; M A Smits
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

6.  Use of an Actinobacillus pleuropneumoniae multiple mutant as a vaccine that allows differentiation of vaccinated and infected animals.

Authors:  Alexander Maas; Ilse D Jacobsen; Jochen Meens; Gerald-F Gerlach
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

7.  Influence of Serum and Glucose Additives on Survival of Actinobacillus pleuropneumoniae Aerosolized from the Freeze-Dried State.

Authors:  A Hensel
Journal:  Appl Environ Microbiol       Date:  1994-06       Impact factor: 4.792

8.  Pathogenesis of porcine Actinobacillus pleuropneumonia: Part I. Effects of surface components of Actinobacillus pleuropneumoniae in vitro and in vivo.

Authors:  H Huang; A A Potter; M Campos; F A Leighton; P J Willson; W D Yates
Journal:  Can J Vet Res       Date:  1998-04       Impact factor: 1.310

9.  Interference of peptides and specific antibodies with the function of the Actinobacillus pleuropneumoniae transferrin-binding protein.

Authors:  K Strutzberg; B Franz; G F Gerlach
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

10.  The transferrin binding protein B of Moraxella catarrhalis elicits bactericidal antibodies and is a potential vaccine antigen.

Authors:  L E Myers; Y P Yang; R P Du; Q Wang; R E Harkness; A B Schryvers; M H Klein; S M Loosmore
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.